Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
NCT00051662 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2005-06-24
Summary
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of psoriatic arthritis (PsA)
Conditions
Interventions
- DRUG
-
efalizumab
Sponsors & Collaborators
-
XOMA (US) LLC
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2004-02-29
More Related Trials
-
A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
NCT02960490 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
NCT00646386 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis
NCT01009086 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RO5310074 in Patients With Psoriatic Arthritis
NCT01199809 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
NCT01078610 ·Status: WITHDRAWN
-
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
NCT05055934 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate
NCT02969044 ·Status: COMPLETED ·Phase: PHASE2
-
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
NCT01087788 ·Status: COMPLETED ·Phase: PHASE3
-
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
NCT02294227 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
NCT02267642 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
NCT04115748 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
NCT07223138 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Study of Golimumab in Participants With Active Psoriatic Arthritis
NCT02181673 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
NCT06624228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT03896581 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
NCT03151551 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)
NCT03162796 ·Status: COMPLETED ·Phase: PHASE3
-
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
NCT05511519 ·Status: TERMINATED ·Phase: PHASE2
-
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
NCT00760669 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
NCT04115839 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis
NCT00265096 ·Status: COMPLETED ·Phase: PHASE3
-
Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
NCT03031782 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
NCT05071664 ·Status: COMPLETED ·Phase: PHASE2
-
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
NCT04062695 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
NCT03486457 ·Status: COMPLETED ·Phase: PHASE3